653A9358 kl.jpg

Developing endolysins and phages as therapeutics

Our purpose

The accelerating antibiotics crisis requires decisive action. Antibiotics frequently fail and destroy our natural microbiomes. Phages and endolysins work where antibiotics fail and protect our beneficial bacteria. They are our best bet to defuse this existential crisis for modern medicine.

Our lead program PM-477:

Bacterial vaginosis (BV)

Recurrent bacterial vaginosis affects 100 million women across the globe. Today’s therapy relies on long-term suppressive antibiotics that fail to provide a cure. Our engineered lysin works where antibiotics fail and is precise, making it a highly innovative solution.

Patient view - BV.png

Are you suffering from BV?

At PhagoMed, we are working to design the best possible therapies for bacterial vaginosis. If you are willing to share your experience with bacterial vaginosis, please click on the link below to complete the survey.


About lysins and phages

Phages have been around since the earliest days of evolution. Phages are natural viruses that hunt and infect bacteria. They then use lysins to break open the cell wall and kill the bacteria.

PhagoMed is member of

PhagoMed is supported by

Latest News

PhagoMed Biopharma GmbH

Leberstraße 20

1110 Vienna



Imprint & Privacy Policy